C12N 2502/14
Hepatocytes
Official title: hepatocytes
C12N2502/14 (Hepatocytes) appears on 70 US grants and 171 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 171
- Assignees
- 109
- Inventors
- 360
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 9 |
| 2003 | 0 | 5 |
| 2004 | 3 | 5 |
| 2005 | 0 | 4 |
| 2006 | 3 | 10 |
| 2007 | 0 | 7 |
| 2008 | 5 | 6 |
| 2009 | 3 | 6 |
| 2010 | 2 | 5 |
| 2011 | 1 | 4 |
| 2012 | 0 | 2 |
| 2013 | 1 | 0 |
| 2014 | 0 | 7 |
| 2015 | 4 | 2 |
| 2016 | 2 | 5 |
| 2017 | 0 | 6 |
| 2018 | 1 | 9 |
| 2019 | 4 | 11 |
| 2020 | 2 | 12 |
| 2021 | 6 | 9 |
| 2022 | 1 | 9 |
| 2023 | 5 | 7 |
| 2024 | 7 | 12 |
| 2025 | 7 | 11 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Media and methods for differentiating natural killer cells1 Sep 2026US 12,723,233 B2Stemcell Technologies Canada Inc.
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells28 Jul 2026US 12,692,479 B2Arizona Board of Regents on behalf of Arizona State University
- Human pluripotent adult stem cells2 Jun 2026US 12,644,098 B2
- Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis7 Apr 2026US 12,594,303 B2Brexogen Inc.
- Clinical gene signature-based human cell culture model and uses thereof25 Nov 2025US 12,480,096 B2Icahn School of Medicine at Mount Sinai
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- Liver disease regulatory formulation and use thereof27 Aug 2026US 2026/0248860 A1Shanghai Celliver Biotechnology Co., Ltd.
- Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells6 Aug 2026US 2026/0226415 A1IntegriCulture Inc.
- Scalable Expansion of CD71+ Erythroid Progenitor Cells for Cell Therapy16 Apr 2026US 2026/0102431 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Feeder cells, cell sheet, production method for feeder cells and cell sheet, and method of maintaining or proliferating cells using feeder cell26 Mar 2026US 2026/0085290 A1Dai Nippon Printing Co.Ltd.
Most cited
By later US patents
- Transgenic swine compositions and methods282US 5,942,435 ABiotechnology Research and Development Corporation · 1999
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006
- Transgenic swine compositions and methods114US 5,523,226 ABiotechnology Research and Development Corporation · 1996
- Co-cultivation of cells in a micropatterned configuration110US 6,133,030 AMassachusetts Institute of Technology · 2000